CAPR
Capricor Therapeutics Inc
NASDAQ: CAPR · HEALTHCARE · BIOTECHNOLOGY
$33.58
+3.45% today
Updated 2026-04-30
Market cap
$2.04B
P/E ratio
—
P/S ratio
124.43x
EPS (TTM)
$-2.26
Dividend yield
—
52W range
$4 – $40
Volume
1.3M
Capricor Therapeutics Inc (CAPR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $380835.00 | $101400.00 | — | — | — | $1.35M | $195500.00 | $503233.00 | $4.17M | $3.78M | $3.19M | $1.37M | $1.67M | $1.01M | $310250.00 | $244898.00 | $2.55M | $25.18M | $22.27M | $0.00 |
| Revenue growth (YoY) | — | -73.4% | -100.0% | — | — | — | -85.6% | +157.4% | +728.0% | -9.4% | -15.5% | -57.1% | +22.2% | -39.9% | -69.1% | -21.1% | +941.8% | +886.8% | -11.5% | -100.0% |
| Cost of revenue | — | — | — | — | — | $0.00 | $2.63M | $5.20M | $7.79M | $13.76M | $16.04M | $10.77M | $12.07M | $5.14M | $8.46M | $245697.00 | $21.82M | $36.45M | $49.97M | — |
| Gross profit | $380835.00 | $101400.00 | — | — | — | $1.35M | $195500.00 | $503233.00 | $-3.00M | $-9.98M | $3.19M | $1.37M | $1.67M | $-4.14M | $310250.00 | $244898.00 | $-19.27M | $-11.27M | $-27.70M | — |
| Gross margin | 100.0% | 100.0% | — | — | — | 100.0% | 100.0% | 100.0% | -72.0% | -264.3% | 100.0% | 100.0% | 100.0% | -411.6% | 100.0% | 100.0% | -755.1% | -44.8% | -124.4% | — |
| R&D | $2.70M | $5.12M | $9.48M | $4.47M | $4.08M | $4.14M | $1.02M | $5.20M | $7.79M | $13.76M | $16.04M | $10.77M | $12.07M | $5.14M | $8.46M | $13.57M | $21.82M | $36.45M | $49.97M | $84.45M |
| SG&A | $60404.00 | $4.48M | $3.92M | $3.42M | $2.21M | $2.12M | $1.61M | $2.21M | $3.02M | $4.37M | $4.93M | $4.76M | $4.93M | $3.60M | $5.54M | $7.61M | $10.43M | $12.81M | $14.87M | $22.75M |
| Operating income | $-60404.00 | $-9.50M | $-13.40B | $-7.88B | $-6.29M | $-4.90M | $-2.44M | $-6.90M | $-6.02M | $-12.61M | $-16.98M | $-12.86M | $-15.33M | $-7.73M | $-13.69M | $-20.94M | $-29.70M | $-24.08M | $-42.56M | $-108.14M |
| Operating margin | -15.9% | -9368.8% | — | — | — | -361.5% | -1248.1% | -1371.7% | -144.4% | -334.0% | -532.2% | -940.8% | -917.0% | -769.5% | -4412.6% | -8549.9% | -1163.9% | -95.6% | -191.1% | — |
| EBITDA | $-60404.00 | $-9.47M | $-13.02M | $-7.71M | $-6.02M | $-4.88M | $-2.43M | $-6.88M | $-5.97M | $-12.50M | $-16.85M | $-12.72M | $-15.17M | $-7.56M | $-13.55M | $-20.69M | $-29.16M | $-23.01M | $-41.14M | $-108.14M |
| EBITDA margin | -15.9% | -9342.2% | — | — | — | -359.9% | -1244.5% | -1366.4% | -143.4% | -331.1% | -528.2% | -930.2% | -907.6% | -752.4% | -4366.2% | -8449.5% | -1143.0% | -91.4% | -184.7% | — |
| EBIT | $-60404.00 | $-9.50M | $-13.13M | $-7.87M | $-6.03M | $-4.88M | $-2.44M | $-6.90M | $-6.02M | $-12.61M | $-16.98M | $-12.86M | $-15.33M | $-7.73M | $-13.69M | $-20.94M | $-29.70M | $-24.08M | $-42.56M | — |
| Interest expense | $950.00 | $1.09M | $137.00 | $0.00 | $0.00 | $0.00 | $0.00 | $58134.00 | $200505.00 | $248626.00 | $344665.00 | $398807.00 | $0.00 | $0.00 | $0.00 | $1.04M | $1.70M | — | $0.00 | $3.05M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-61354.00 | $-10.30M | $-13.13M | $-7.87M | $-6.03M | $-4.88M | $-1.89M | $-8.89M | $-6.22M | $-12.86M | $-18.81M | $2.43M | $-15.19M | $-7.64M | $-13.66M | $-20.02M | $-29.02M | $-22.29M | $-40.47M | $-105.04M |
| Net income growth (YoY) | — | -16692.7% | -27.5% | +40.1% | +23.4% | +19.0% | +61.2% | -369.7% | +30.1% | -106.8% | -46.3% | +112.9% | -724.8% | +49.7% | -78.7% | -46.6% | -44.9% | +23.2% | -81.6% | -159.6% |
| Profit margin | -16.1% | -10160.7% | — | — | — | -360.5% | -968.3% | -1767.0% | -149.2% | -340.5% | -589.5% | 177.8% | -908.9% | -760.4% | -4401.9% | -8175.9% | -1137.4% | -88.5% | -181.7% | — |